1. Home
  2. SID vs VCEL Comparison

SID vs VCEL Comparison

Compare SID & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SID
  • VCEL
  • Stock Information
  • Founded
  • SID 1941
  • VCEL 1989
  • Country
  • SID Brazil
  • VCEL United States
  • Employees
  • SID N/A
  • VCEL N/A
  • Industry
  • SID Steel/Iron Ore
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SID Industrials
  • VCEL Health Care
  • Exchange
  • SID Nasdaq
  • VCEL Nasdaq
  • Market Cap
  • SID 1.9B
  • VCEL 2.1B
  • IPO Year
  • SID 1997
  • VCEL 1997
  • Fundamental
  • Price
  • SID $1.52
  • VCEL $31.25
  • Analyst Decision
  • SID Strong Sell
  • VCEL Strong Buy
  • Analyst Count
  • SID 1
  • VCEL 6
  • Target Price
  • SID $1.30
  • VCEL $60.60
  • AVG Volume (30 Days)
  • SID 2.0M
  • VCEL 811.4K
  • Earning Date
  • SID 11-11-2025
  • VCEL 11-06-2025
  • Dividend Yield
  • SID 5.32%
  • VCEL N/A
  • EPS Growth
  • SID N/A
  • VCEL 2045.40
  • EPS
  • SID N/A
  • VCEL 0.13
  • Revenue
  • SID $8,202,474,486.00
  • VCEL $249,119,000.00
  • Revenue This Year
  • SID $4.37
  • VCEL $18.35
  • Revenue Next Year
  • SID $0.51
  • VCEL $22.47
  • P/E Ratio
  • SID N/A
  • VCEL $224.93
  • Revenue Growth
  • SID 2.22
  • VCEL 16.13
  • 52 Week Low
  • SID $1.24
  • VCEL $29.94
  • 52 Week High
  • SID $2.50
  • VCEL $63.00
  • Technical
  • Relative Strength Index (RSI)
  • SID 61.12
  • VCEL 39.79
  • Support Level
  • SID $1.26
  • VCEL $29.93
  • Resistance Level
  • SID $1.59
  • VCEL $33.25
  • Average True Range (ATR)
  • SID 0.05
  • VCEL 1.70
  • MACD
  • SID 0.01
  • VCEL -0.20
  • Stochastic Oscillator
  • SID 65.22
  • VCEL 15.84

About SID Companhia Siderurgica Nacional S.A.

Companhia Siderurgica Nacional is an integrated steel producer. together with its subsidiaries operates in five main business segments: Steel industry: production and marketing of flat and long steels; Mining: extraction, processing and marketing of iron ore, tin, limestone and dolomite; Cement: production and commercialization of bagged and bulk cement, in addition to aggregates, concrete, and other related products; Energy: generation and sale of energy from almost all renewable sources; and Logistics: participations in railways and port terminals. The group generates the majority of its revenue from the Steel industry segment. Geographically, it derives a majority of revenue from Asia.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: